The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
This page provides hospital pharmacists with information on open consultations that are being conducted by EAHP, the European Medicines Agency, the European Commission and any other entities or individuals.
EAHP
No open consultation at the moment.
European Commission
No open consultation at the moment.
European Medicines Agency (EMA)
No open consultation at the moment.
EDQM
No open consultation at the moment.
Others
Due date | Name of consultation | Scope of consultation |
17/01/2025 | Greek Panhellenic Association of Hospital Pharmacists (PEFNI) survey on FMD implementation |
Following the extension for Greece and Italy, the Falsified Medicine Directive (FMD) is set to come into force for both countries on the 9 February 2025. To support Greek hospital pharmacists with their implementation of the FMD, the Greek Panhellenic Association of Hospital Pharmacists (PEFNI) prepared a short survey to collect the experience of countries who already have been implementing the Directive. EAHP members are invited to respond to the short survey prepared by PEFNI in English. |